Emergent BioSolutions Inc. (EBS) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $9.49 (+4.00%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
EBS vs Sector & Market
| Metric | EBS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 19 |
| Target Upside | +26.4% | +1710.9% | +16.4% |
| P/E Ratio | 8.89 | 3.29 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $182M | $186M | $190M | 2 |
| 2026-09-30 | $197M | $202M | $206M | 1 |
| 2026-12-31 | $198M | $203M | $207M | 1 |
| 2027-03-31 | $220M | $225M | $230M | 1 |
| 2027-06-30 | $205M | $210M | $215M | 1 |
| 2027-09-30 | $225M | $230M | $235M | 1 |
| 2027-12-31 | $222M | $227M | $232M | 1 |
| 2028-12-31 | $877M | $879M | $880M | 1 |
| 2029-12-31 | $961M | $963M | $965M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.11 | $0.11 | $0.11 | 1 |
| 2026-09-30 | $0.24 | $0.25 | $0.26 | 1 |
| 2026-12-31 | $0.40 | $0.41 | $0.42 | 1 |
| 2027-03-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2027-06-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2027-09-30 | $0.00 | $0.00 | $0.00 | 0 |
| 2027-12-31 | $0.00 | $0.00 | $0.00 | 0 |
| 2028-12-31 | $0.43 | $0.43 | $0.43 | 1 |
| 2029-12-31 | $0.90 | $0.90 | $0.90 | 1 |
Frequently Asked Questions
What is the analyst consensus for EBS?
The consensus among 2 analysts covering Emergent BioSolutions Inc. (EBS) is Buy with an average price target of $51.50.
What is the highest price target for EBS?
The highest analyst price target for EBS is $65.00.
What is the lowest price target for EBS?
The lowest analyst price target for EBS is $38.00.
How many analysts cover EBS?
2 analysts have issued ratings for Emergent BioSolutions Inc. in the past 12 months.
Is EBS a buy or sell right now?
Based on 2 analyst ratings, EBS has a consensus rating of Buy (2.00/5) with a +26.4% upside to the consensus target of $51.50.
What are the earnings estimates for EBS?
Analysts estimate EBS will report EPS of $0.11 for the period ending 2026-06-30, with revenue estimated at $186M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.